Klein Hersh Blog

In the fast-paced, ever-changing pharmaceutical, biotech, and healthcare industries, every moment counts when determining the strategy for filling critical leadership gaps. Whether bridging a temporary vacancy or engaging the precise expertise required during a critical phase, an increasing number of companies are relying on interim staffing and consultants to address immediate needs for top-tier talent. “We’re seeing companies of all ...

A Q&A Session with Klein Hersh’s Kate Jeffries When San Francisco native Kate Jeffries was considering where to build her career in healthcare executive recruitment, she quickly realized relocating to Philadelphia to join Klein Hersh was the best move. We sat down with Kate to talk about her newly created position at the firm, the increasing demand for talent in ...

A Q&A Session with Klein Hersh’s Amanda Zlotnikoff From preclinical organizations to commercial pharma and biotech companies, securing exceptional leadership in the role of chief executive officer (CEO) and across a company’s board of directors is paramount to success. We sat down with our own Amanda Zlotnikoff to discuss how the CEO and Board practice area at Klein Hersh helps ...

During “Heart Month” in February, We Celebrate Our Colleagues’ Passion Projects From American Heart Month to Valentine’s Day, we all hold February close to our hearts. So, it seems a perfect time of year to reflect on what fills our hearts. Beyond our beloved family and friends, and the lifechanging science we’re fortunate enough to support in our professional lives, ...

It’s the start of a new year – a clean slate, blank canvas, whatever you want to call it, you’ve got a new year on your hands. And while you might be using the reset to tackle new health and wellness goals, it’s also an important time to jot down some business objectives, no matter where you are in your ...

The year 2023 has been a significant one at Klein Hersh, as we marked our 25th anniversary in business. Such a major milestone calls for a healthy dose of reflection, a renewed appreciation for how we got here, and a focus on what we expect the next 25 years will look like. For me, this milestone is especially meaningful. Humble ...

An increasing number of biotech venture capital (VC) firms, early-stage biotech companies, and publicly traded biotechs are making the decision to hire in-house attorneys, rather than outsource this vital function. We sat down with our own Jake Epstein to discuss what’s driving this shift, the benefits of bringing on in-house legal experts, and what companies look for when filling these ...

Authored by Matt Azarva Across numerous industries, in the news, and even at the dinner table, everyone is buzzing about the introduction of artificial intelligence (AI) into our daily lives. In healthcare and life sciences, AI is not a new concept at all, but rather, a vital tool that’s been utilized for years now. That said, we’re just beginning to ...

A Q&A Session with Klein Hersh’s Jason Hersh and Jesse Klein While Philadelphia’s beloved Eagles did not come out on top at this year’s Super Bowl, the team’s exceptional culture, leadership, and resilience have made them winners in every other way. Their capacity to rise above adversity with an eye to the future is a testament to the unshakable foundation ...

The year 2022 has proven to be yet another transformative time across the healthcare sector, as is the norm for most industries still reeling from the impact of a lingering global pandemic. The healthcare sector, specifically, has been both revolutionized with astounding scientific and technological innovation, as well as woefully interrupted by challenging economic realities and market downturn. As business ...